EcoDrugPlus

Insulin Receptor-Like

Ensembl ID : ENSCSEG00000014505
Gene Symbol: LOC103396460
3 Cross references
230 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSCSEG00000014148
Gene Symbol: LOC103393515
3 Cross references
201 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSCSEG00000010813
Gene Symbol: LOC103379307
3 Cross references
204 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSCSEG00000016787
Gene Symbol: LOC103385260
3 Cross references
206 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSCSEG00000016567
Gene Symbol: ITGB3A
1 Cross references
204 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSCSEG00000021594
Gene Symbol: LOC103396775
3 Cross references
230 Possible Orthologues:

Integrin Beta-3

Ensembl ID : ENSCSEG00000007362
Gene Symbol: LOC103381463
3 Cross references
195 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSCSEG00000005226
Gene Symbol: ITGA4
3 Cross references
226 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSCSEG00000008169
Gene Symbol: ITGA5
3 Cross references
196 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSCSEG00000016012
Gene Symbol: ITGAV
3 Cross references
238 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSCSEG00000011836
Gene Symbol: ITGB1
3 Cross references
209 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSCSEG00000003492
Gene Symbol: ITGB5
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).